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Abstract Removal of a peroxisome proliferator from the diet triggered the degradation of peroxisomes and induced the transient expression of a 
220 kDa soluble protein in rat liver. The 220 kDa protein was purified by conventional methods and analyzed by amino acid sequencing. A total 
of 99 amino acid residues in 4 lysylendopeptidase-digested p ptides completely matched those in rat fatty acid synthase. The transient induction of 
fatty acid synthase mRNA during peroxisome degradation was confirmed by Northern blotting. 
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1. Introduction 
Peroxisomes are unique in their ability to proliferate in ro- 
dent liver cells in response to several disparate chemicals, which 
are designated ‘peroxisome proliferators (PP)’ (for a review, see 
[ 11). The molecular mechanism of PP action and its physiolog- 
ical meaning have become clearer after the cDNA cloning of 
a PP-activated receptor (PPAR) (for a review, see [2]). In con- 
trast, the process of reduction in the normal liver after removal 
of PPs is poorly understood. Upon removal of PPs, a dramatic 
decrease in the size and in number of peroxisomes occurs and 
hepatomegaly should be de-induced in a few days. Significant 
changes in metabolism should occur. Though an autophagic 
mechanism has been recently proposed for the degradation of 
the peroxisomes [3,4], the effects of the removal of PPs on other 
cellular processes have only been studied to a small extent [5]. 
Therefore we investigated the induced changes in the rat liver 
after removal of PPs and report here that the expression of fatty 
acid synthase is transiently induced. 
2. Materials and methods 
2.1. Materials 
Clofibrate (2-@-chlorophenoxy)isobutyric acid ethyl ester) was pur- 
chased from Tokyo-Kasei (Tokyo, Japan). DNA polymerase I, DNase 
I and T4 polynucleotide kinase were obtained from Toyobo (Osaka, 
Japan). [$‘P]ATP (-3000 Ciimmol) and [a-32P]dCTP were from ICN 
(Irvine, USA). Fatty acid synthase mRNA was detected using a S-end 
labeled synthetic 25mer oligonucleotide (Sawaday, Tokyo, Japan), 
(complementary to the published cDNA sequence, nucleotide number 
555 to 579 [6]). 
2.2. Feeding rats and preparation of light mitochondrial fraction 
Male Fischer F344 rats (4 months old, 25&300 g) were given a diet 
containing 0.5% (w/w) clofibrate. At the indicated time, the rats were 
anesthetized with ether and decapitated. Post-mitcchondrial fractions 
(PMS) were obtained from a portion of the livers as described [7]. 
2.3. Purification of a 220 kDa protein 
The presence of a 220 kDa protein (P220) was assessed by SDS- 
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PAGE and protein staining. PMS from the livers of the rats refed with 
a normal diet for 2-3 days after receiving that containing clofibrate, was 
centrifuged at 100,000 x g for 60 min at 0“C. Tbe supematant was 
fractionated by ammonium sulfate precipitation (l&40%), and purified 
by ionic exbange chromatography (DE-52, pH 8.5) followed by HPLC 
gel filtration (TSK G30OOSW,,). 
2.4. Amino acid sequencing 
The purified P220 was digested by lysylendopeptidase (20: 1) and the 
peptides were separated by reverse phase HPLC as described [S]. Four 
peptides that were isolated from others on the chromatogram were 
recovered and their amino acid sequences were analyzed by automated 
Edman degradation using a ProSequencer (MilliGen) according to the 
manufacturer’s instructions. 
2.5. Isolation of RNA and Northern blotting 
Total RNA was isolated and analyzed as described [9]. Hybridization 
with a 5’-end labeled synthetic oligonucleotide proceeded in hybridiza- 
tion buffer containing 10% (v/v) formaldehyde, and the membranes 
were washed finally with 2 x SSC, 0.1% SDS at 40 “C. 
3. Results 
3.1. Removal of a PP induced 220 kDa protein 
SDS-PAGE analysis of the proteins in PMS fractions ob- 
tained from rats given clofibrate or a subsequent normal diet, 
showed the induction of peroxisome as assessed by the 77 kDa 
marker protein [lo] at a level of over twenty times that of the 
control level [9], followed by a rapid decrease (Fig. 1). The 
decrease began 2-3 days after the removal of clofibrate from 
the diet and at almost the same time, a 220 kDa protein (P220) 
started to increase for a day or two. The time courses of the 
changes in the levels of the 77 kDa protein and P220 during the 
entire period are shown in Fig. IB. 
3.2. Purification and identification of P220 
P220 was soluble in PMS because almost all of it was recov- 
ered in the supematant after centrifugation at 100,000 x g for 
60 min as assessed by SDS-PAGE (not shown). P220 was thus 
purified from the supematant of PMS obtained from the livers 
of rats fed with clofibrate for 2 weeks followed by a normal diet 
for 2-3 days. The protein was purified almost to homogeneity 
by a combination of conventional methods (see section 2, and 
Fig. 2). 
To identify P220, the lysylendopeptidase-digested peptides 
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Fig. 1. Time course of changes in protein patterns of PMS from the 
livers of rats fed clofibrate. (A) PMS fractions (50 pg protein) were 
prepared from the livers of rats given a control diet (lanes 1 and 2, 
numbered from the left), clofibrate (0.5%) for 5 to 14 days (lanes 37), 
or clofibrate for 14 days and then the control diet for an additional 
1 to 7 days (lanes &12), and analyzed by SDS-PAGE (7.5%). The 
arrowhead at the left shows the position of P220. (B) Tie courses of 
the changes of P220 (0) and the 77 kDa marker protein (A) quantified 
by densitometry of (A). 
were fractionated and the amino acids of 4 peptides (P220-1 to 
P220-4, with retention times at 76, 78, 81 and 83 min, respec- 
tively) were sequenced. The results are summarized in Fig. 3. 
The four peptide sequences were independently searched for 
similarity among data bases and all exactly corresponded to 
portions of the same protein, fatty acid synthase [6]. The molec- 
ular weight in SDS-PAGE and its soluble nature, as well as 
matching in amino acid sequences, all indicated that P220 is 
fatty acid synthase. 
3.3. Northern blots 
To examine the step of regulation at which the level of fatty 
acid synthase is increased, the changes in the level of the syn- 
thase mRNA were measured by Northern blotting (Fig. 4). An 
mRNA larger than 28s rRNA was scarcely detected uring the 
induction period, but it transiently increased 2-3 days after the 
removal of clofibrate, then decreased to the normal level. The 
timing of the increase in the mRNA well corresponded with 
Fig. 2. Purification of P220. P220 was put-i&d by centrifugation from 
the PMS fraction from the livers of the rats given the normal diet for 
2-3 days after that containing clofibrate (SlO), ammonium sulfate frao 
tionation (AS), DE-52 column chromatography (DE52), and HPLC gel 
filtration (TSK G3OOOSW). A portion of each fraction (l-3 pg) was 
analyzed for purity by SDS-PAGE followed by silver staining. The 
arrowhead on the left indicates the position of P220 and the molecular 
weights are shown in kDa on the right. 
that in the protein levels, confirming that the induced P220 is 
fatty acid synthase and suggesting that the increase was medi- 
ated by activation of the transcription rate and/or in stabiliza- 
tion of the mRNA. 
4. Discussion 
The induction and de-induction of peroxisomal /?-oxidation 
and the microsomal w-hydroxylation enzymes for fatty acids 
should be co-regulated with other enzymes in lipid metabolism 
to maintain lipid homeostasis. Fatty acid synthase, which plays 
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FAS: 
Fig. 3. Amino acid sequences of lysylendopeptidase-digested fragments 
in alignment with the published sequences of rat fatty acid synthase 
(FAS). The residues indicated by an ‘x’ could not be identified. Those 
substituted by ‘=’ in the published sequences are the same as those 
which we identified. 
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quires further study [2]. The sequence TGTCCAATGGTCT 
(located at nucleotides -509 to -496) is present in the promoter 
region of the rat FAS gene [13]. It is composed of a possible 
PPAR binding motif TGTCCA, a one-base spacer, and 
TGGTCT, which is homologous to the TGGACA motif found 
in the PPAR heterodimer binding sites in the promoters of the 
rat apolipoprotein CIII [ 141 and P450 IVA [ 151 genes. Changes 
in the levels of other enzymes as well as the cellular pool of fatty 
acids in relation to PP action should be studied to understand 
how complex lipid metabolism is regulated and the role of 
PPAR. 
Fig. 4. Northern blots of changes in the levels of fatty acid synthase 
mRNA (A), peroxisomal thiolase mRNA (B), and control a,, globulin 
mRNA (C). Arrow heads indicate the time of addition (left) and with- 
drawal (right) of clofibrate. See Fig. 1 for a detailed schedule. 
a central role in de novo lipogenesis by catalyzing all of the 
reactions in the conversion of acetyl-CoA and malonyl-CoA to 
palmitate [ll], may be one of these enzymes. The hormonal 
regulation of FAS gene transcription has been studied in detail 
[11,12], but there is no data at present about involvement of 
PPAR in its transcriptional regulation. The ability of PPARs 
to form a heterodier with various transcription factors re- 
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